Drugmakers are also making significant headway in developing and releasing generic versions of GLP-1 medications, with the FDA approving the first 2 generic GLP-1 drugs in November and December 2024, respectively, although neither of those drugs has weight-loss-specific uses
Next-Generation Modalities Cutting-edge platforms such as: RNA and gene-silencing technologies DNA-encoded therapeutics are opening entirely new possibilities for precision metabolic interventions
Support staff should gather histories and labs before the provider visit
At Formation, peptide therapy and PRP treatments are administered by Jeff Atlas, PA-C, a physician assistant with a background in orthopedics who brings hands-on expertise in musculoskeletal health, regenerative techniques, and injection precision to every session
doi: 10.1016/j.diabres.2020.108120 69
Many facilities in Panama City offer follow-up consultations during the final days of the trip